Mimetic peptide of ubiquitin-interacting motif of epsin as a cancer therapeutic-perspective in brain tumor therapy through regulating VEGFR2 signaling
Year: 2017
Type: article
Abstract: . Specifically targeting VEGFR2 in the tumor vasculature, the chemically synthesized chimeric UIM peptide, UPI, causes non-functional tumor angiogenesis, retards tumor growth, and increases survival rates in several tumor models. The authors showed that UPI binds ubiquitylated VEGFR2 to form a supercomplex in an Ub-dependent fashion. Collectively, the UPI targeting strategy offers a potentially novel treatment for cancer patients who are resistant to current anti-angiogenic therapies. In this review, the authors outline the main points of this research specifically as a potential application for glioma tumor therapy.
Source: Vessel Plus
Authors: Yunzhou Dong, Hao Wu, Jerry Dong, Kai Song, Habibunnabi Ashiqur Rahman, Rheal Towner, Hong Chen
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: diamond
Funders: American Heart Association, Oklahoma Center for the Advancement of Science and Technology, Oklahoma Medical Research Foundation, Institut National de la Santé et de la Recherche Médicale, National Institutes of Health, National Heart, Lung, and Blood Institute, National Center for Research Resources
OpenAlex ID: W2748957979
